Long-term benefit of Qarziba uncertain, says NICE
admin 4th May 2018 Uncategorised 0The National Institute for Health and Care Excellence has ruled against the provision of NHS funding for EUSA Pharma’s neuroblastoma treatment Qarziba.
More: Long-term benefit of Qarziba uncertain, says NICE
Source: News